To be designated as an antiamaril vaccination centre, establishments, services or organisations must:
1° Maintain or set up a team of professionals, the composition and number of whom are adapted to local needs and the activity of the centre. The doctor in charge of the team must hold a university degree in either tropical medicine or travel medicine. A doctor with the equivalent of at least three years’ professional experience in a yellow fever vaccination centre may also perform this role. In areas where antiamaril vaccination is compulsory for residents, these requirements are waived by specific training in antiamaril vaccination;
2° Open the centre at least half a day a week;
3° Ensure the presence of a doctor on the premises during the centre’s opening hours;
4° Guarantee the availability of premises suited to the centre’s activities;
5° Guarantee the availability of the equipment and materials required for vaccinations;
6° Guarantee compliance with the cold chain, in particular by means of a medical refrigerator equipped with an internal temperature control system;
7° Ensure the availability of vaccines for reserved use that are required or recommended for certain journeys;
8° Guarantee the availability of the equipment and medicines needed to treat any serious adverse reactions;
9° Guarantee compliance with regulations on the disposal of waste from healthcare activities involving infectious risk;
10° Guarantee the availability of information and advice, particularly on the prevention of diseases that can be transmitted during journeys and the offer of an individual interview. This information and advice must comply with the recommendations validated by the Haut Conseil de la Santé Publique (High Council for Public Health) concerning, in particular, the vaccination calendar and health recommendations for travellers;
11° Ensure the issue of yellow fever vaccination certificates that comply with the International Health Regulations and include the date, the batch number of the vaccine, the official stamp of the authorised centre and the signature of the vaccinator;
12° Report to the regional pharmacovigilance centre any adverse reactions that may be due to vaccines, under the conditions set out in section 13 of chapter I of title II of book I of part five.